Oncology Med, Inc. (Other OTC: ONCO.PK) reported the addition of Mitchell Jarosz, M.S., DABR to the Oncology Med Advisory Board.
Dr. William J. Walker, chairman of Oncology Med, Inc., stated, “Mitchell Jarosz is a welcome addition to our advisory board and he will bring a practical and clinical analysis to our discussions of our expansion of services in addition to our quality control and assessment of our existing services.”
Oncology Med is a public company engaged in the fulfillment of services related to the treatment of various cancers. It currently provides analysis and design of radiation treatment plans in order for radiation oncologists to administer radiation plans to cancer patients. Current services facilitate radiation treatment programs ranging from external beam radiation to more advanced radiation treatment technologies.
Let us hear your thoughts below:
